ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ikarugamycin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

16 träffar

Bibliografisk träff 2023-07-01

Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses.

Zhang S, Zhao L, Guo M, Liu P, Li S, Xie W, Tian AL, Pol JG, Chen H, Pan H, Mao M, Li Y, Zitvogel L, Jin Y, Kepp O, Kroemer G.

J Immunother Cancer · research support, non-u.s. gov't; research-article; journal article · DOI 10.1136/jitc-2023-006785

Bibliografisk träff 2021-09-25

Antibacterial Activity of Ikarugamycin against Intracellular <i>Staphylococcus aureus</i> in Bovine Mammary Epithelial Cells In Vitro Infection Model.

Saeed SI, Aklilu E, Mohammedsalih KM, Adekola AA, Mergani AE, Mohamad M, Kamaruzzaman NF.

Biology (Basel) · research-article; journal article · DOI 10.3390/biology10100958

Bibliografisk träff 2021-07-08

A potent endocytosis inhibitor Ikarugamycin up-regulates TNF production.

Minamidate A, Onizawa M, Saito C, Hikichi R, Mochimaru T, Murakami M, Sakuma C, Asakawa T, Hiraoka Y, Oshima S, Nagaishi T, Tsuchiya K, Ohira H, Okamoto R, Watanabe M.

Biochem Biophys Rep · brief-report; journal article · DOI 10.1016/j.bbrep.2021.101065

Bibliografisk träff 2020-02-13

Engineered Biosynthesis of 5/5/6 Type Polycyclic Tetramate Macrolactams in an Ikarugamycin (5/6/5 Type)-Producing Chassis.

Jin H, Zhang W, Zhang G, Zhang L, Liu W, Zhang C.

Org Lett · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.orglett.9b04672

Bibliografisk träff 2020-01-16

Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2.

Jiang SH, Dong FY, Da LT, Yang XM, Wang XX, Weng JY, Feng L, Zhu LL, Zhang YL, Zhang ZG, Sun YW, Li J, Xu MJ.

FASEB J · research support, non-u.s. gov't; journal article · DOI 10.1096/fj.201901237r

Bibliografisk träff 2020-01-15

Isoborneol Attenuates Low-Density Lipoprotein Accumulation and Foam Cell Formation in Macrophages.

Wang Y, Li Z, Liu B, Wu R, Gong H, Su Z, Zhang S.

Drug Des Devel Ther · research-article; journal article · DOI 10.2147/dddt.s233013

Bibliografisk träff 2017-01-27

Biocatalytic Total Synthesis of Ikarugamycin.

Greunke C, Glöckle A, Antosch J, Gulder TA.

Angew Chem Int Ed Engl · research support, non-u.s. gov't; journal article · DOI 10.1002/anie.201611063

Bibliografisk träff 2016-08-08

Ikarugamycin: A Natural Product Inhibitor of Clathrin-Mediated Endocytosis.

Elkin SR, Oswald NW, Reed DK, Mettlen M, MacMillan JB, Schmid SL.

Traffic · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/tra.12425

Bibliografisk träff 2015-03-01

Promiscuous hydroxylases for the functionalization of polycyclic tetramate macrolactams--conversion of ikarugamycin to butremycin.

Greunke C, Antosch J, Gulder TA.

Chem Commun (Camb) · research support, non-u.s. gov't; journal article · DOI 10.1039/c5cc00843c

Bibliografisk träff 2014-04-06

Mechanistic insights into polycycle formation by reductive cyclization in ikarugamycin biosynthesis.

Zhang G, Zhang W, Zhang Q, Shi T, Ma L, Zhu Y, Li S, Zhang H, Zhao YL, Shi R, Zhang C.

Angew Chem Int Ed Engl · research support, non-u.s. gov't; journal article · DOI 10.1002/anie.201402078

Bibliografisk träff 2014-02-12

Heterologous reconstitution of ikarugamycin biosynthesis in E. coli.

Antosch J, Schaefers F, Gulder TA.

Angew Chem Int Ed Engl · research support, non-u.s. gov't; journal article · DOI 10.1002/anie.201310641

Bibliografisk träff 2013-04-12

Streptomyces harbinensis sp. nov., an endophytic, ikarugamycin-producing actinomycete isolated from soybean root [Glycine max (L.) Merr].

Liu C, Wang X, Zhao J, Liu Q, Wang L, Guan X, He H, Xiang W.

Int J Syst Evol Microbiol · research support, non-u.s. gov't; journal article · DOI 10.1099/ijs.0.050088-0

Bibliografisk träff 2011-03-12

Ikarugamycin induces DNA damage, intracellular calcium increase, p38 MAP kinase activation and apoptosis in HL-60 human promyelocytic leukemia cells.

Popescu R, Heiss EH, Ferk F, Peschel A, Knasmueller S, Dirsch VM, Krupitza G, Kopp B.

Mutat Res · journal article · DOI 10.1016/j.mrfmmm.2011.03.001

Bibliografisk träff 2001-03-01

Human immunodeficiency virus type 1 Nef-induced CD4 cell surface downregulation is inhibited by ikarugamycin.

Luo T, Fredericksen BL, Hasumi K, Endo A, Garcia JV.

J Virol · research support, u.s. gov't, p.h.s.; research-article; journal article · DOI 10.1128/jvi.75.5.2488-2492.2001

Bibliografisk träff 1992-04-01

Inhibition of the uptake of oxidized low-density lipoprotein in macrophage J774 by the antibiotic ikarugamycin.

Hasumi K, Shinohara C, Naganuma S, Endo A.

Eur J Biochem · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1432-1033.1992.tb16848.x

Bibliografisk träff 1972-05-01

A new antibiotic, ikarugamycin.

Jomon K, Kuroda Y, Ajisaka M, Sakai H.

J Antibiot (Tokyo) · journal article · DOI 10.7164/antibiotics.25.271